| Schedule of Segment Reporting Information, by Segment |
The following table is a comparative summary of the Company’s net sales and segment profit for by reportable segment for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended |
| |
|
|
|
December 31,
2022 |
|
December 31,
2021 |
Segment Net Revenue: |
|
|
|
|
|
|
|
| Cannabinoid |
|
|
|
|
$ |
6,119
|
|
|
$ |
3,242 |
|
| Non-Cannabinoid |
|
|
|
|
11,681
|
|
|
12,132 |
|
| Total Net Revenue |
|
|
|
|
17,800
|
|
|
15,374 |
|
| |
|
|
|
|
|
|
|
Segment Profit (Loss):
|
|
|
|
|
|
|
|
| Cannabinoid |
|
|
|
|
(63,720) |
|
|
(16,915) |
|
| Non-Cannabinoid |
|
|
|
|
1,346
|
|
|
2,631 |
|
| Total Loss |
|
|
|
|
$ |
(62,374) |
|
|
$ |
(14,284) |
|
| |
|
|
|
|
|
|
|
Reconciliation:
|
|
|
|
|
|
|
|
| Total Segment Loss |
|
|
|
|
(62,374) |
|
|
(14,284) |
|
| Unallocated corporate expenses |
|
|
|
|
(8,327) |
|
|
(11,196) |
|
| Non-cash share based compensation |
|
|
|
|
(2,343) |
|
|
(11,451) |
|
| Depreciation and amortization |
|
|
|
|
(2,058) |
|
|
(1,768) |
|
|
|
|
|
|
|
|
|
| Goodwill impairment |
|
|
|
|
—
|
|
|
(18,508) |
|
| Loss from operations |
|
|
|
|
$ |
(75,102) |
|
|
$ |
(57,207) |
|
| |
|
|
|
|
|
|
|
| Loss (gain) on debt extinguishment, net |
|
|
|
|
2,263
|
|
|
(3,262) |
|
| Gain on remeasurement of warrant liability |
|
|
|
|
(2,092) |
|
|
(16,856) |
|
| Gain on investment |
|
|
|
|
(6,851) |
|
|
— |
|
| Foreign exchange loss |
|
|
|
|
1,129
|
|
|
1,276 |
|
| Interest expense |
|
|
|
|
2,702
|
|
|
6,818 |
|
| Other expense (income), net |
|
|
|
|
202
|
|
|
(502) |
|
| Loss from operations before income taxes and equity investment loss |
|
|
|
|
$ |
(72,455) |
|
|
$ |
(44,681) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
2022 |
|
December 31,
2021 |
Long-lived assets
|
|
|
|
| Cannabinoid |
$ |
15,308
|
|
|
$ |
30,709 |
|
Non-Cannabinoid |
155
|
|
|
216 |
|
Other(a)
|
—
|
|
|
7 |
|
| Total |
$ |
15,463
|
|
|
$ |
30,932 |
|
____________ (a)“Other” includes long-lived assets primarily in the Company’s corporate offices.
|
| Schedule of Revenue by Major Customers by Reporting Segments |
Customers with an accounts receivable balance of 10% or greater of total accounts receivable and customers with net revenue of 10% or greater of total revenues are presented below for the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of Revenues |
|
Percentage of Accounts Receivable |
|
December 31, |
|
December 31, |
|
2022 |
2021 |
|
2022 |
2021 |
|
|
|
|
|
|
Customer B (a)
|
12% |
17% |
|
18% |
25% |
Customer C (b)
|
* |
* |
|
13% |
18% |
Customer H (a)
|
* |
* |
|
15% |
* |
Customer I (a)
|
* |
* |
|
10% |
* |
* denotes less than 10%
(a) net sales attributed are reflected in the cannabinoid segments
(b) net sales attributed are reflected in the non-cannabinoid segments
|
| Disaggregation of Revenue |
The following table disaggregates the Company’s revenues by channel for the periods presented:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended |
|
|
|
|
|
December 31,
2022 |
|
December 31,
2021 |
| Mass retail |
|
|
|
|
$ |
9,920
|
|
|
$ |
8,070 |
|
| Distributors |
|
|
|
|
6,796
|
|
|
5,835 |
|
| Specialty, health and other retail |
|
|
|
|
578
|
|
|
945 |
|
| E-commerce |
|
|
|
|
506
|
|
|
524 |
|
|
|
|
|
|
$ |
17,800
|
|
|
$ |
15,374 |
|
|
| Revenue from External Customers by Geographic Areas |
The following table represents the Company's revenues attributed to countries based on location of customer:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2022 |
2021 |
| United States |
$ |
11,461
|
|
|
$ |
12,132 |
|
| Israel |
1,424
|
|
|
$ |
809 |
|
| Australia |
1,835
|
|
|
1,584 |
|
| Brazil |
1,431
|
|
|
153 |
|
| Germany |
1,431
|
|
|
100 |
|
| Other |
218
|
|
|
596 |
|
| Total |
$ |
17,800
|
|
|
$ |
15,374 |
|
(a) The Company has presented December 31, 2021 information to conform to the current period presentation.
|